© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2020;12(10):5265-5268 | http://dx.doi.org/10.21037/jtd.2020.04.44 Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and scarring lung disease characterized by irreversible decline in lung function leading to chronic respiratory failure (1). About 5 million of people are affected globally (2) and average life expectancy following diagnosis is about 4 years. Health Related Quality of life (HRQoL) is low and characterized by symptoms such as shortness of breath, dry cough and limited exercise tolerance (3,4).
Idiopathic pulmonary fibrosis management: Caring is sparing
Nava S.;Prediletto I.
2020
Abstract
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2020;12(10):5265-5268 | http://dx.doi.org/10.21037/jtd.2020.04.44 Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and scarring lung disease characterized by irreversible decline in lung function leading to chronic respiratory failure (1). About 5 million of people are affected globally (2) and average life expectancy following diagnosis is about 4 years. Health Related Quality of life (HRQoL) is low and characterized by symptoms such as shortness of breath, dry cough and limited exercise tolerance (3,4).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Carig is Sparing 2020 Editorial.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione
107.39 kB
Formato
Adobe PDF
|
107.39 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
